Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 3:45 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Fairmount Funds Management LLC | 6,018,465 9.900% | 2,258,955 (+60.09%) | Filing History |
| 2023-02-14 1:37 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Armistice Capital, LLC | 3,147,200 4.990% | 446,401 (+16.53%) | Filing History |
| 2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | VIKING GLOBAL INVESTORS LP | 6,162,362 9.990% | 177,628 (+2.97%) | Filing History |
| 2023-02-10 4:25 pm Sale | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | TPG GP A, LLC | 0 0.000% | -4,824,883 (Position Closed) | Filing History |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Rubric Capital Management LP | 5,684,420 9.490% | 5,684,420 (New Position) | Filing History |
| 2022-10-07 5:29 pm Purchase | 2022-09-27 | 13G | Trevi Therapeutics, Inc. TRVI | VIKING GLOBAL INVESTORS LP | 5,984,734 9.990% | 5,984,734 (New Position) | Filing History |
| 2022-10-07 2:51 pm Purchase | 2022-10-05 | 13G | Trevi Therapeutics, Inc. TRVI | Frazier Life Sciences Public Fund, L.P. | 6,663,590 11.400% | 2,847,131 (+74.60%) | Filing History |
| 2022-04-25 5:04 pm Purchase | 2022-04-11 | 13D | Trevi Therapeutics, Inc. TRVI | New Enterprise Associates 16, L.P. | 14,370,376 42.500% | 6,580,526 (+84.48%) | Filing History |
| 2022-04-21 4:05 pm Purchase | 2022-04-11 | 13G | Trevi Therapeutics, Inc. TRVI | Venrock Healthcare Capital Partners II, L.P. | 3,668,334 9.990% | 3,668,334 (New Position) | Filing History |
| 2022-04-21 10:00 am Purchase | 2022-04-11 | 13G | Trevi Therapeutics, Inc. TRVI | Fairmount Funds Management LLC | 3,759,510 9.900% | 3,759,510 (New Position) | Filing History |
| 2022-04-18 1:32 pm Purchase | 2022-04-11 | 13G | Trevi Therapeutics, Inc. TRVI | Frazier Life Sciences Public Fund, L.P. | 3,816,459 10.000% | 3,816,459 (New Position) | Filing History |
| 2022-04-08 10:41 am Purchase | 2022-03-30 | 13G | Trevi Therapeutics, Inc. TRVI | MAI Capital Management | 1,541,471 5.000% | 1,541,471 (New Position) | Filing History |
| 2022-03-09 5:09 pm Purchase | 2022-02-28 | 13G | Trevi Therapeutics, Inc. TRVI | Rosalind Advisors Inc. | 2,185,664 8.500% | 2,185,664 (New Position) | Filing History |
| 2022-03-09 11:18 am Purchase | 2022-03-07 | 13G | Trevi Therapeutics, Inc. TRVI | Nemean Asset Management, LLC | 1,340,000 5.180% | 1,340,000 (New Position) | Filing History |
| 2022-02-14 5:16 pm Purchase | 2021-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Armistice Capital, LLC | 2,700,799 9.990% | 2,700,799 (New Position) | Filing History |
| 2022-02-11 4:16 pm Purchase | 2022-01-12 | 13G | Trevi Therapeutics, Inc. TRVI | TPG GP A, LLC | 4,824,883 18.700% | 4,824,883 (New Position) | Filing History |
| 2022-01-26 4:15 pm Unchanged | 2021-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Lundbeckfond Invest A/S | 1,151,544 4.500% | 0 (Unchanged) | Filing History |
| 2021-11-02 09:09 am Purchase | 2021-10-18 | 13D | Trevi Therapeutics, Inc. TRVI | New Enterprise Associates 16, L.P. | 7,789,850 36.100% | 1,851,852 (+31.19%) | Filing History |
| 2021-02-12 4:54 pm Sale | 2020-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | TPG Group Holdings (SBS) Advisors Inc. | 4,824,883 26.200% | -1,499,436 (-23.71%) | Filing History |
| 2020-04-16 4:26 pm Purchase | 2020-04-03 | 13D | Trevi Therapeutics, Inc. TRVI | New Enterprise Associates 16, L.P. | 5,937,998 33.300% | 1,499,436 (+33.78%) | Filing History |